Escherichia coli enteritis medical therapy

Jump to navigation Jump to search

Escherichia coli enteritis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Escherichia coli enteritis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Treatment

Medical Therapy

Surgery

Prevention

Escherichia coli enteritis medical therapy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Escherichia coli enteritis medical therapy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Escherichia coli enteritis medical therapy

CDC on Escherichia coli enteritis medical therapy

Escherichia coli enteritis medical therapy in the news

Blogs on Escherichia coli enteritis medical therapy

Directions to Hospitals Treating Type chapter name here

Risk calculators and risk factors for Escherichia coli enteritis medical therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Yazan Daaboul, M.D.; Serge Korjian M.D.

Overview

Rehydration is the mainstay of therapy of E. coli enteritis. Oral rehydration fluids (e.g. oral rehydration solutions) are indicated among patients who can tolerate oral intake, otherwise IV rehydration is indicated. Since the majority of cases of E. coli enteritis are self-limited and the exact infective strain is often not identified, empiric antimicrobial therapy is generally not recommended. Antimicrobial therapy using either fluoroquinolone or TMP-SMX may be administered (but is not required) in ETEC infection (traveler's diarrhea), EPEC infection, and EIEC infection, but not in EHEC infection (due to increased risk of hemolytic uremic syndrome and prolonged shedding). In adults, additional pharmacologic therapies may include antiemetic agents (not recommended in pediatric patients). Antidiarrheal agents are generally not recommended during the acute infection phase.

Medical Therapy

Rehydration

Antimicrobial Therapy

Other Pharmacologic Agents

  • 1. Escherichia coli species
  • 1.1. Enterotoxigenic E. coli (ETEC)
  • 1.2. Enteropathogenic E. coli (EPEC)
  • 1.3. Enteroinvasive E. coli (EIEC)
  • 1.4. Enterohemorrhagic E. coli (EHEC)

References